[Asia Economy Reporter Hyunseok Yoo] IntroMedic, a company specializing in video diagnostic medical devices, succeeded in turning a net profit in the first quarter.


On the 13th, IntroMedic announced that it recorded a net profit of 294.5 million KRW on a separate basis in the first quarter of this year, marking a return to profitability. During the same period, the consolidated net profit also turned positive at 33.89 million KRW, and consolidated sales increased by 137% year-on-year to 1.8 billion KRW.


It was explained that sales related to capsule endoscopy significantly increased in overseas markets including China, the UK, and Australia, and that the sale of shares in a subsidiary enabled the company to achieve a net profit turnaround in the first quarter.


An IntroMedic official stated, “IntroMedic is a technology-specialized listed company, so market actions due to operating losses are exempted, but we are always striving to improve the company’s growth, shareholder value, and profitability,” adding, “Having started the first quarter with positive results, we will continue to work hard to ensure continuous sales growth and profitability improvement in both existing and new business areas.”


Since last year, IntroMedic has focused on expanding the Chinese market and established a capsule endoscopy factory in Taizhou City, Jiangsu Province, China, capable of producing 300,000 units annually, in partnership with Richen-force Science & Technology, the exclusive distributor of capsule endoscopy in China.


Going forward, the company plans to continuously invest in its core business of capsule endoscopy and actively expand domestic and international sales activities. The new disinfectant business is also expected to create synergies in various directions alongside quarantine gates and sterilization robots.



Meanwhile, IntroMedic is currently engaged in related business by investing in Cyworld Jet, the operator of Cyworld, which is scheduled to reopen at the end of May. The company has announced plans to invest in both existing and new businesses using funds raised through a rights offering and convertible bond issuance.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing